C A Penning

Monoclonal autoantibody from a (new zealand black x new zealand white)F₁ mouse and some human scleroderma sera target an <i>MT</i>_r 34,000 nucleolar protein of the U3 RNP particle

Georg Reimer, K. Michael Pollard, C A Penning et al. · Arthritis & Rheumatism · 1987 · 253 citations

Life Sciences, Immunology, Molecular Biology +17

Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)

Georg Reimer, Virginia Steen, C A Penning et al. · Arthritis & Rheumatism · 1988 · 212 citations

Life Sciences, Immunology, Pathology +12

Characterization of human poly(ADP-ribose) polymerase with autoantibodies.

Hisashi Yamanaka, C A Penning, Erik H. Willis et al. · Journal of Biological Chemistry · 1988 · 116 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer

Rebecca Kristeleit, Vadim Shirinkin, Fatima El-Khouly et al. · Gynecologic Oncology · 2017 · 101 citations · Full text

Medicine, Oncology, Pharmacology +15

Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP-ribose)polymerase in Escherichia coli. Lysine 893 is critical for activity.

Frédéric Simonin, Josiane Ménissier‐de Murcia, Olivier Poch et al. · Journal of Biological Chemistry · 1990 · 86 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16